FDA Inspection 1032257 — Milford Regional Medical Center, Inc.
The FDA completed an inspection of Milford Regional Medical Center, Inc. on October 20, 2017 in Milford, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 20, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Milford, MA (United States)